GSE111061 1 V 0 TOFACITINIB HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE111061 1 V 0 TOFACITINIB HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE111061 1 V 0 TOFACITINIB HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE111061 1 V 0 TOFACITINIB HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE111061 1 V 0 TOFACITINIB HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

microtubule associated protein 7

Gene

keratin 14

Gene

secretory leukocyte peptidase inhibitor

Gene

cytochrome P450 family 1 subfamily B member 1

Gene

cell division cycle 20

Gene

serpin family A member 1

Gene

transmembrane 4 L six family member 1

Gene

ChaC glutathione specific gamma-glutamylcyclotransferase 1

Gene

tubulin beta 2A class IIa

Gene

gap junction protein alpha 1

  • Gene

    microtubule associated protein 7



  • Gene

    secretory leukocyte peptidase inhibitor


  • Gene

    cytochrome P450 family 1 subfamily B member 1


  • Gene

    cell division cycle 20


  • Gene

    serpin family A member 1


  • Gene

    transmembrane 4 L six family member 1


  • Gene

    ChaC glutathione specific gamma-glutamylcyclotransferase 1


  • Gene

    tubulin beta 2A class IIa


  • Gene

    gap junction protein alpha 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.